Covered recipient · General Payments record
ANDREA WIELAND
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$1,295.85
- Reported across 68 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $341.00 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $213.42 | 12 |
| Exeltis, USA Inc. | $53.00 | 3 |
| Bayer HealthCare Pharmaceuticals Inc. | $50.69 | 2 |
| Astellas Pharma Global Development | $23.89 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $15.83 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208119 | CMS |
| Amgen Inc. | $16.36 | 02/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208123 | CMS |
| Amgen Inc. | $18.40 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208128 | CMS |
| Amgen Inc. | $24.35 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208132 | CMS |
| Amgen Inc. | $8.28 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208138 | CMS |
| Amgen Inc. | $19.87 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208142 | CMS |
| Amgen Inc. | $18.84 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208146 | CMS |
| Amgen Inc. | $13.58 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208150 | CMS |
| Amgen Inc. | $25.02 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208154 | CMS |
| Amgen Inc. | $15.05 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208162 | CMS |
| Amgen Inc. | $25.20 | 10/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208158 | CMS |
| Amgen Inc. | $12.64 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116208166 | CMS |
| Astellas Pharma Global Development | $23.89 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132965565 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $19.56 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086272736 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $31.13 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086309121 | CMS |
| Exeltis, USA Inc. | $16.41 | 07/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150021521 | CMS |
| Exeltis, USA Inc. | $18.34 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150021523 | CMS |
| Exeltis, USA Inc. | $18.25 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150021525 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.